
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [BPMC] Blueprint Medicines Corp
Data updated 2025-Mar-07 (Friday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Mar-07 Friday
Open | $89.32 | High | $90.00 +0.76% |
---|---|---|---|
Close | $87.07 | Low | $86.98 -2.62% |
Volume | 792 Thousand 1.23x | Volatility | 3.47% |
Change |
$-1.47
-1.66%
|
Streak | ↓ 2 days -3.17% |
20d SMA | $94.16 -7.5% | 50d SMA | $98.98 -12.0% | 100d SMA | $95.67 -9.0% | 200d SMA | $97.82 -11.0% |
RSI | 34 | MACD | -0.6 | ADX | 25.5 | Stochastic Oscillator | 21.6 20.8 |
CCI | -105.6 | ATR | 4.02 | OBV | 16.7 Million | Chaikin A/D | 14.7 Million |
Market Cap | 5.4 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 21.4 | Price/Book (mrq) | 41.4 | EV/Revenue (ttm) | 20.2 | EV/EBITDA (ttm) | -10.7 |
% Held by Insiders | 0.90% | % Held by Institutions | 106.48% | Shares Short | 5.14 M | Shares Short (prior month) | 4.6 M |
Short Ratio | 5.33 | Short % of Outstanding | 8.39% | Short % of Float | 8.49% | Shares Short Change (mom) | +11.7% |
Revenue/Share (ttm) | $4.12 | Profit Margin (ttm) | -203.30% | Operating Margin (ttm) | -146.07% | EBITDA (ttm) | -475 M |
Diluted EPS (ttm) | $-8.37 | Current Ratio (mrq) | 3.76 | Return on Assets (ttm) | -25.34% | Return on Equity (ttm) | -157.13% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 85.50% | Operating Cash Flow (ttm) | -437 M | Free Cash Flow (ttm) | -239 M | |
Choose view type
Daily Performance for Blueprint Medicines Corp. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Blueprint Medicines Corp up to close of 2025-Mar-07 at $87.07
1-week Performance Benchmarks for Blueprint Medicines Corp:
Related to Blueprint Medicines Corp
Information for Blueprint Medicines Corp
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-07 on Google
SEC Reports : Quarterly reports around 2025-Mar-07 on SEC Edgar
Compare Blueprint Medicines Corp with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Blueprint Medicines Corp
Industry : Biotechnology industry performance which includes Blueprint Medicines Corp